Skip to content
naulon
Not checkedNot checked for notices yet.

Role of immune-pineal axis in neurodegenerative diseases, unraveling novel hybrid dark hormone therapies

Nitya Beriwal, Tashi Namgyal, Pema Sangay and 1 more

Heliyon · 2019

doi:10.1016/j.heliyon.2019.e01190 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

The anti-oxidant effects of melatonin and the immune-pineal axis are well established. However, how they play a role in the pathogenesis of neurodegenerative diseases is not well elucidated. A better understanding of this neuro-immuno-endocrinological link can help in the development of novel therapies with higher efficacy to alleviate symptomatology, slow disease progression and improve the quality of life. Recent studies have shown that the immune-pineal axis acts as an immunological buffer, neurohormonal switch and it also intricately links the pathogenesis of neurodegenerative diseases (like Multiple sclerosis, Alzheimer's disease, Parkinson's disease) and inflammation at a molecular level. Furthermore, alteration in circadian melatonin production is seen in neurodegenerative diseases. This review will summarise the mechanics by which the immune-pineal axis and neuro-immuno-endocrinological disturbances affect the pathogenesis and progression of neurodegenerative diseases. It will also explore, how this understanding will help in the development of novel hybrid melatonin hormone therapies for the treatment of neurodegenerative diseases.

Abstract licence: CC BY-NC-ND

References101

  1. 10.

39 more references, whose wording the paper’s licence keeps private.

All 101 references

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.